BRPI1006135A2 - Bactérias do ácido láctico e seu uso em produtos microbianos para ração direta a suínos - Google Patents

Bactérias do ácido láctico e seu uso em produtos microbianos para ração direta a suínos

Info

Publication number
BRPI1006135A2
BRPI1006135A2 BRPI1006135A BRPI1006135A BRPI1006135A2 BR PI1006135 A2 BRPI1006135 A2 BR PI1006135A2 BR PI1006135 A BRPI1006135 A BR PI1006135A BR PI1006135 A BRPI1006135 A BR PI1006135A BR PI1006135 A2 BRPI1006135 A2 BR PI1006135A2
Authority
BR
Brazil
Prior art keywords
strains
strain
nrrl
swine
lactic acid
Prior art date
Application number
BRPI1006135A
Other languages
English (en)
Inventor
Ellen Davis Mari
Rehberger Joshua
maxwell Charles
Rehberger Thomas
King Mike
Original Assignee
Danisco
The Bd Of Trustees Of The Univ Of Arkansas Acting For & On Behalf Of The Univ Arkansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco, The Bd Of Trustees Of The Univ Of Arkansas Acting For & On Behalf Of The Univ Arkansas filed Critical Danisco
Publication of BRPI1006135A2 publication Critical patent/BRPI1006135A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)

Abstract

BACTÉRIAS DO ÁCIDO LÁCTICO E SEU USO EM PRODUTOS MICROBIANOS PARA RAÇÃO DIRETA A SUÍNOS. A presente invenção refere-se a TRF's úteis na identificação de cepas de interesse. Um método de identificação de uma ou mais cepas que podem ser usadas como um produto microbiano para alimentação direta também é proporcionado. Uma ou mais cepas identificadas por meio do método são adicionalmente proporcionadas. Um método é também proporcionado para administração, a um animal, de uma quantidade eficaz da uma ou mais cepas. Adicionalmente proporcionada é uma cepa isolada escolhida de pelo menos uma da cepa PIB c6 de Lactobacillus acidophilus (NRRL B50103), cepa o246e 33w de Lactobacillus salivarius (NRRL B-50102), cepa o246e 42 de Pediococcus acidilactici (NRRL B-50171) e cepa PIJ e3 de Pediococcus acidilactici (NRRL B-50101). Uma cepa isolada tendo todas as características identificadas de uma das cepas listadas acima é também proporcionada. Uma ou mais cepas podem ser administradas como um produto microbiano para alimentação direta a um animal. Métodos de preparo de um produto microbiano para alimentação direta são também proporcionados.
BRPI1006135A 2009-01-12 2010-01-12 Bactérias do ácido láctico e seu uso em produtos microbianos para ração direta a suínos BRPI1006135A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14399009P 2009-01-12 2009-01-12
PCT/US2010/020746 WO2010081138A1 (en) 2009-01-12 2010-01-12 Lactic acid bacteria and their use in swine direct-fed microbials

Publications (1)

Publication Number Publication Date
BRPI1006135A2 true BRPI1006135A2 (pt) 2017-08-15

Family

ID=42316872

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006135A BRPI1006135A2 (pt) 2009-01-12 2010-01-12 Bactérias do ácido láctico e seu uso em produtos microbianos para ração direta a suínos

Country Status (9)

Country Link
US (3) US8563295B2 (pt)
EP (1) EP2376660A4 (pt)
JP (1) JP5770640B2 (pt)
CN (1) CN102272332A (pt)
AU (1) AU2010203379B2 (pt)
BR (1) BRPI1006135A2 (pt)
CA (1) CA2749178C (pt)
MX (1) MX2011007423A (pt)
WO (1) WO2010081138A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2748300T3 (en) 2011-08-24 2019-01-14 Dupont Nutrition Biosci Aps ENZYM-PRODUCING BACILLUS STUMS
DK2852691T3 (da) 2012-05-21 2017-11-27 Dupont Nutrition Biosci Aps Lactobacillusstammer med antimykotiske egenskaber
AU2013265388B2 (en) 2012-05-21 2015-10-29 Dupont Nutrition Biosciences Aps Strains of propionibacterium
EP3229595B1 (en) * 2014-12-12 2021-02-03 The Regents of the University of California Reduction of milk glycans and their degradation products in the neonate gut
WO2018126026A1 (en) 2016-12-28 2018-07-05 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
ES2978111T3 (es) 2015-06-25 2024-09-05 Native Microbials Inc Métodos, aparatos y sistemas para analizar cepas de microorganismos de comunidades heterogéneas complejas, predecir e identificar relaciones funcionales e interacciones de las mismas, y seleccionar y sintetizar conjuntos microbianos basados en las mismas
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
MX2019007760A (es) 2016-12-28 2020-02-10 Ascus Biosciences Inc Metodos, aparatos y sistemas para analisis de cepa de microorganismo de comunidades heterogeneas complejas con analisis rastreador, determinacion de relaciones funcionales e interacciones de estas, y sintesis de agrupaciones microbianas que incluyen agrupaciones microbianas dosificadas y agrupaciones microbianas inoculativas.
CN107034163B (zh) * 2017-05-23 2020-03-10 北京市农林科学院 一种新型乳酸片球菌及其应用
KR102130646B1 (ko) * 2018-10-15 2020-07-06 주식회사 제일바이오 신규한 락토바실러스 살리바리우스 및 이를 유효성분으로 포함하는 양식 어류 및 갑각류용 사료첨가제
JP2022523564A (ja) 2019-03-04 2022-04-25 アイオーカレンツ， インコーポレイテッド 機械学習を使用するデータ圧縮および通信
KR102064134B1 (ko) * 2019-09-10 2020-01-08 재단법인 농축산용미생물산업육성지원센터 신균주 페디오코쿠스 에시딜락티시 cacc 537 및 이를 유효성분으로 함유하는 반려동물용 사료 조성물
KR102278911B1 (ko) * 2020-08-10 2021-07-19 주식회사 잇다 사육 단계별 양돈 사료 급여 방법
CN112266880B (zh) * 2020-10-20 2022-05-13 青岛普罗百世生物科技有限公司 一种嗜酸乳杆菌及其在断奶仔猪饲料中的应用
CN115141780B (zh) * 2022-07-19 2023-06-02 重庆市畜牧科学院 一种复合微生物菌剂及其应用
CN115341044A (zh) * 2022-10-19 2022-11-15 佛山科学技术学院 一种利用微生物及其相关snp位点预测猪日增重的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1155148T3 (da) 1999-03-01 2006-06-12 Lapuco Invest N V Detektering og kvantificering af mikroorganismer under anvendelse af amplifikation og restriktionsenzymanalyse
EP1130114A1 (en) 2000-03-03 2001-09-05 Dr. van Haeringen Laboratorium B.V. Universal variable fragments
US7734688B2 (en) * 2000-09-28 2010-06-08 Qwest Communications International Inc. Portable wireless player and associated method
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
WO2004009031A2 (en) * 2002-07-22 2004-01-29 Agtech Products, Inc. Lactobacillus strains and uses therefor
WO2004104175A2 (en) 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
DE10326175B3 (de) * 2003-06-10 2005-02-10 Siemens Ag Tablettenpresse

Also Published As

Publication number Publication date
JP2012514980A (ja) 2012-07-05
US8563295B2 (en) 2013-10-22
AU2010203379A1 (en) 2011-07-07
US9011877B2 (en) 2015-04-21
CN102272332A (zh) 2011-12-07
WO2010081138A1 (en) 2010-07-15
CA2749178C (en) 2015-10-20
MX2011007423A (es) 2011-08-12
EP2376660A1 (en) 2011-10-19
AU2010203379B2 (en) 2011-11-24
US9402871B2 (en) 2016-08-02
US20140120137A1 (en) 2014-05-01
US20100183574A1 (en) 2010-07-22
US20150190436A1 (en) 2015-07-09
JP5770640B2 (ja) 2015-08-26
EP2376660A4 (en) 2012-11-21
CA2749178A1 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
Willing et al. Changes in faecal bacteria associated with concentrate and forage‐only diets fed to horses in training
Cooper et al. Virulence of Clostridium perfringens in an experimental model of poultry necrotic enteritis
MX2011007423A (es) Bacterias de acido lactico y su uso en agentes microbianos de alimentacion directa a cerdos.
Broom et al. Effects of zinc oxide and Enterococcus faecium SF68 dietary supplementation on the performance, intestinal microbiota and immune status of weaned piglets
Forte et al. Effects of two different probiotics on microflora, morphology, and morphometry of gut in organic laying hens
Roto et al. An introduction to the avian gut microbiota and the effects of yeast-based prebiotic-type compounds as potential feed additives
Hook et al. Methanogens: methane producers of the rumen and mitigation strategies
Vicente et al. Effect of a selected Lactobacillus spp.–based probiotic on Salmonella enterica serovar Enteritidis–infected broiler chicks
Skřivanová et al. Influence of pH on antimicrobial activity of organic acids against rabbit enteropathogenic strain of Escherichia coli
Geier et al. Comparison of alternatives to in‐feed antimicrobials for the prevention of clinical necrotic enteritis
Ayaz et al. Prevalence and molecular characterization of sorbitol fermenting and non-fermenting Escherichia coli O157: H7+/H7–isolated from cattle at slaughterhouse and slaughterhouse wastewater
US10238695B2 (en) Use of microorganisms for reducing the level of trimethylamine in a human body cavity, in particular for the treatment of trimethylaminuria or of bacterial vaginosis and the prevention of cardiovascular diseases
Nordeste et al. Molecules produced by probiotics prevent enteric colibacillosis in pigs
AR047067A1 (es) Metodos para el uso de bifidobacterias probioticas para animales de compania
BR112013016690A2 (pt) agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante
Vicente et al. Effect of a Lactobacillus species-based probiotic and dietary lactose prebiotic on turkey poult performance with or without Salmonella enteritidis challenge
Chen et al. Impact of enrofloxacin and florfenicol therapy on the spread of OqxAB gene and intestinal microbiota in chickens
Trckova et al. Prophylaxis of post-weaning diarrhoea in piglets by zinc oxide and sodium humate.
Long et al. Effects of the acid-tolerant engineered bacterial strain Megasphaera elsdenii H6F32 on ruminal pH and the lactic acid concentration of simulated rumen acidosis in vitro
Rahimi et al. Effect of direct-fed microbials on performance and Clostridium perfringens colonization of turkey poults
Xie et al. Comparative evaluation of spores and vegetative forms of Bacillus subtilis and bacillus licheniformis on probiotic functionality In vitro and In vivo
Soto et al. Effects of bacterial inoculants in milk on the performance of intensively reared calves
Ozutsumi et al. The mcrA gene and 16S rRNA gene in the phylogenetic analysis of methanogens in the rumen of faunated and unfaunated cattle
Gong et al. Saccharomyces cerevisiae live cells decreased in vitro methane production in intestinal content of pigs
Shojadoost et al. Effects of virginiamycin against experimentally induced necrotic enteritis in broiler chickens vaccinated or not with an attenuated coccidial vaccine

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]